2016•PubMedRequires access

[Choice of Adjuvant Chemotherapy Based on Breast Cancer Subtype].

Hiroko Shimada, Nobuko Fujiuchi, Toshiaki Saeki

Abstract

Adjuvant chemotherapy targets micrometastases. If micrometastases are destroyed, patients with breast cancer will be cured. Currently, in Japan, standard breast cancer therapy is decided based on subtypes that are defined according to ER, PgR, HER2, and Ki-67 expression. We present here an outline of the recommended chemotherapy regimens based on evidence.

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Medicine, Breast cancer, Oncology, Chemotherapy, Adjuvant, Internal medicine, Adjuvant chemotherapy, Cancer